In HCC induced by non‐alcoholic fatty liver disease (NAFLD), terbinafine promotes SQLE degradation via autophagy and subsequently restores PTEN expression, effectively inhibiting the AKT/mTOR signaling pathway [174]. Here, PTEN is linked to metabolic dysfunction-associated steatotic liver disease.